GERD (acid reflux) Board decisions

The appeal for a higher disability rating for GERD has been dismissed.

The Board denied service connection for heart condition, sleep apnea, plantar fasciitis, hernia condition, GERD, PTSD, right ear hearing loss, and left ear hearing loss.

The Board denied the veteran's claims for increased ratings for chronic bronchitis, PTSD, major depressive disorder, alcohol use disorder and traumatic brain injury/post-concussional syndrome, and GERD.

The Board denied an increased rating in excess of 10 percent for GERD with hiatal hernia, finding that the Veteran's symptoms did not result in considerable or severe impairment of health.

The Board dismissed the veteran's appeals for increased ratings and service connection due to improper concurrent elections and a spurious February 2024 rating decision.

The Board denied service connection for GERD, a low testosterone condition including erectile dysfunction, and obstructive sleep apnea as these conditions were not incurred in or caused by active-duty service.

The Board granted service connection for hyperthyroidism and denied service connection for glaucoma, sleep apnea, lung condition (including COPD and asthma), GERD, breast cancer, IBS, blood clots, and heart condition. The claims for bilateral hearing loss and tinnitus were remanded.

The Board remands the claims for service connection for gastroesophageal reflux disease (GERD) and obstructive sleep apnea (OSA) due to insufficient evidence.

The Board denied service connection for a gastrointestinal disability, including GERD and hiatal hernia, as it is not related to any injury, disease, or event incurred in service, or to the service-connected orthopedic and psychiatric disabilities.

The Board denied the veteran's claim for an initial rating in excess of 10 percent for gastroesophageal reflux disease (GERD) based on the evidence not demonstrating a considerable or severe impairment of health.

The Board denied service connection for sinusitis and remanded claims for gastroesophageal reflux disease, migraine headaches, rhinitis, cervical spine disability, left shoulder disability, and right shoulder disability.

The Board denied service connection for mid/lower back, right shoulder, right and left knee, bilateral flatfoot, GERD, irritable bowel syndrome (IBS)/irritable colon, and bilateral hearing loss disorders. The claim for CHF was remanded for further development.

The Board granted restoration of the 10% rating for GERD and the 20% rating for right knee traumatic degenerative joint disease, while denying a higher rating for both conditions.

The Board granted a 30 percent rating for GERD with hiatal hernia and a 40 percent rating for right lower extremity radiculopathy (sciatic nerve), but remanded the claims for service connection for insomnia and special monthly compensation based on the need for regular aid and attendance of another person.

The Board granted service connection for asthma and GERD, effective March 8, 2023.

The Board denied service connection for multiple conditions, including GERD, neck injury, right knee injury, left knee injury, shrapnel wound to the lower left leg, right ankle injury, left ankle injury, RLE neuropathy, and lower back injury.

The Board denied the Veteran's claims for revision of a February 1997 rating decision on the basis of clear and unmistakable error (CUE) due to the failure to adjudicate service connection for hyperthyroidism, traumatic brain injury, and a higher initial rating for gastroesophageal reflux disease.

The Board denied service connection for multiple conditions, including bilateral hearing loss, cervical stenosis of the spine, acid reflux, erectile dysfunction, and chronic hemorrhoids. The remaining claims for degenerative joint disease in various parts of the body were remanded for further development.

The Board granted a higher initial rating of 30 percent for the Veteran's service-connected GERD, finding that the disability is productive of considerable impairment of health.

The Board granted an initial rating of 30 percent for GERD with hiatal hernia, effective from February 23, 2021.